Trial Profile
Effect of zotarolimus-eluting stent in acute coronary syndrome patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 May 2015
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 14 May 2015 New trial record